Concepedia

Jennifer Lauchle

JL

15

Publications

1.2K

Citations

15

H-Index

2004

Active since

Affiliations

University of California, San Francisco(Current)

Dana-Farber Cancer Institute

Tennessee Oncology

Memorial Sloan Kettering Cancer Center

The University of Texas Southwestern Medical Center

Jennifer Lauchle is an author at University of California, San Francisco specializing in medicine, tumor biology, and cancer research.

ORCID

Top concepts

Publications per year

2004–2021

15

Publications

15

Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder

Doan Le, Namie Kong, Yuan Zhu et al. · Blood · 2004 · 172 citations · Full text

Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras

Jennifer Lauchle, Doris Kim, Doan Le et al. · Nature · 2009 · 148 citations · Full text

, , +11

Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors

Saoirse Dolly, Andrew J. Wagner, Johanna C. Bendell et al. · Clinical Cancer Research · 2016 · 131 citations · Full text

Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice

Tiffany Chang, Kimberly Krisman, Emily Harding Theobald et al. · Journal of Clinical Investigation · 2012 · 118 citations · Full text

, , +15

A multicenter, single‐arm, open‐label, phase 2 study of apitolisib (GDC‐0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study)

Vicky Makker, Fernando O. Recio, Ling Ma et al. · Cancer · 2016 · 96 citations · Full text

Rows per page

1–5 of 15